Inhibition of bispecific monoclonal antibody (bsAb)‐targeted cytolysis by human anti‐mouse antibodies in ovarian carcinoma patients treated with bsAb‐targeted activated T‐lymphocytes [PDF]
, 1995 C. B. H. W. Lamers +4 more
openalex +1 more source
European Journal of Heart Failure, EarlyView.Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta‐analysis. Clonal haematopoiesis and heart failure: a meta‐analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure. [Correction added on 15 March 2025, after first online publication: The graphical image was corrected in ...
Paschalis Karakasis +8 more
wiley +1 more source
FcαRI (CD89) as a Novel Trigger Molecule for Bispecific Antibody Therapy [PDF]
, 1997 Thomas Valerius +10 more
openalex +1 more source
Targeting T cells against brain tumors with a bispecific ligand‐antibody conjugate [PDF]
, 1998 Edward J. Roy +4 more
openalex +1 more source
A REVIEW ON BISPECIFIC ANTIBODIES
, 2019 Antibodies are widely recognized for their therapeutic potential and subsequently have prompted a lot of interest into their development and application. The structure of monoclonal IgG antibody is represented, with the heavy chains in rose and the light chains in green.
openaire +1 more source
ELECTROPHORESIS, EarlyView.ABSTRACT This review provides an in‐depth exploration of capillary electrophoresis–mass spectrometry (CE–MS) in biomolecular research from 2020 to 2024. CE–MS emerges as a versatile and powerful tool due to its numerous advantages, facilitating the analysis of various biomolecules, including proteins, peptides, oligonucleotides, and other metabolites ...
Laura Pont +2 more
wiley +1 more source
Construction of a diabody (small recombinant bispecific antibody) using a refolding system [PDF]
, 2000 Shin-ichi Takemura +12 more
openalex +1 more source
Bispecific antibodies in follicular lymphoma
HaematologicaBispecific antibodies, specifically anti-CD20 T-cell engaging constructs, are poised to alter the treatment paradigm of multiple B-cell malignancies, including follicular lymphoma. Two CD20xCD3 bispecific antibodies, mosunetuzumab and epcoritamab, are now approved in the United States for third-line or later treatment of follicular lymphoma.
Imran A. Nizamuddin, Nancy L. Bartlett
openaire +3 more sources
CD3 directed bispecific antibodies induce increased lymphocyte–endothelial cell interactions in vitro [PDF]
, 2000 Grietje Molema +5 more
openalex +1 more source
Protein-environment-sensitive computational epitope accessibility analysis from antibody dose-response data [PDF]
arXivAntibodies are widely used in life-sciences and medical therapy. Yet, broadly applicable methods are missing to determine, in the biological system of choice, antibody specificity and its quantitative contribution to e.g. immunofluorescence stainings. Thereby, antibody-based data often needs to be seen with caution.
arxiv